All News #Library
Biotech
Toragen Pharma Secures $12m Convertible Note, Expands Board
30 Sep 2025 //
BUSINESSWIRE
Toragen Updates Ph 1 Trial of TGN-S11 in HPV-Associated Cancers
15 Apr 2025 //
BUSINESSWIRE
Toragen Updates Data from Ph 1 Trial of TGN-S11 in HPV Cancers
18 Nov 2024 //
BUSINESSWIRE
Toragen, Inc. Announces Initiation of Phase 1 Trial of TGN-S11 i
30 Jun 2023 //
BUSINESSWIRE
Toragen, Inc. Announces FDA Acceptance of IND Application for TGN-S11
28 Feb 2023 //
BUSINESSWIRE

Market Place
Sourcing Support